Letters to the EditorPrenatal Therapy in Developmental Disorders: Drug Targeting via Intra-Amniotic Injection to Treat X-Linked Hypohidrotic Ectodermal Dysplasia
Under an Elsevier user license
open archive
Cited by (0)
Kenneth Huttner is an employee of Edimer Pharmaceuticals Inc.; Pascal Schneider holds shares in this company. Holm Schneider is a member of the clinical advisory board of Edimer Pharmaceuticals.
Copyright © 2014 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights reserved.